Ulrich Langenkamp

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

Stefan Diermayr, Heike Himmelreich, Bojana Müller-Durovic et al. · Blood · 2007 · 214 citations

Life Sciences, Cell Biology, Immunology +16

Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis

A Rohner, Ulrich Langenkamp, Uwe Siegler et al. · Leukemia Research · 2007 · 107 citations

Life Sciences, Immunology, Oncology +13

β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio

Juergen Luhm, Ulrich Langenkamp, Jenny Hensel et al. · BMC Immunology · 2006 · 34 citations · Full text

Life Sciences, Immunology, Cellular Immunology +16

Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells

Ulrich Langenkamp, Uwe Siegler, Simon Jörger et al. · Haematologica · 2009 · 29 citations · Full text

Life Sciences, Immunology, Oncology +17